New 5-Year, $15 Million Research Grant Program to Accelerate Immune Tolerance Therapies for Type 1 Diabetes
The Juvenile Diabetes Research Foundation (JDRF), the world's leading charitable supporter of research into type 1 diabetes and its complications, today announced a new, 5-year $15 million joint funding program with the NIH-supported Immune Tolerance Network (ITN) that is aimed at accelerating the pace of clinical research towards a cure for type 1 diabetes. The JDRF-ITN Partnership in Immune Tolerance program will fund early-stage clinical trials and late stage preclinical development of potential immune tolerance-inducing treatments for type 1 diabetes.&nb